RE: Neil Young4 Feb 2022 13:55
PART 2
This is before mitigation and according to Billboard there has been an uptick in consumption of Young’s music as a result of the publicity, with his reputation enhanced for taking a stance on an issue that costs him money…it is even possible that any short term direct impact is more than offset by higher than expected revenues from other sources.
Being permanently off Spotify could have an impact in terms of the value of that catalogue, but his fan base will still find ways to listen to him and with the catalogue probably no more than 2-3% of overall NAV it would have minimal overall impact given the revenue mix from that catalogue. And it is possible that higher consumption of his music elsewhere as a result of his now higher profile more than offsets any loss from Spotify. It has also been suggested that SONG’s 50% interest does not give Hipgnosis much say in how to use Young’s music to generate additional revenue. Yet this is clearly by design given that Neil Young is uncompromising about how his music is used, and this would have been reflected in the acquisition price and the contract that SONG signed with him. However, even where SONG has full copyright control and owns 100%, it has built its reputation on being sensitive to how the music is used…and this is why artists are happy to partner with Hipgnosis even if it may not offer the highest price.
Our live NAVe for SONG is $1.725, or 127.3pps. The shares have weakened recently and at 115.6pps (@9.00) are trading on a discount of 9.2%. This is a substantial discount to Round Hill Music which is trading on an estimated discount of 2.6%. In our view the rating of SONG is unjustified based on the quality of the two portfolios and, to the extent it is the result of concerns about the financial impact from Neil Young, is, in our view, totally overdone. Thus we see current weakness as a buying opportunity and reiterate our Overweight recommendation.